tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Eliana Merle, 219 are a BUY (83.91%), 41 are a HOLD (15.71%), 1 are a SELL (0.38%).
Analyst Eliana Merle, currently employed at BARCLAYS, carries an average stock price target met ratio of 42.97% that have a potential upside of 38.09% achieved within 187 days. Previously, Eliana Merle worked at UBS, CANTOR FITZGERALD.
Eliana Merle’s has documented 519 price targets and ratings displayed on 47 stocks. The coverage is on Healthcare, Financial Services sectors.
Most recent stock forecast was given on RARE, Ultragenyx at 05-Nov-2026.
Analyst best performing recommendations are on RAPT (RAPT THERAPEUTICS).
The best stock recommendation documented was for RAPT (RAPT THERAPEUTICS) at 5/22/2025. The price target of $8 was fulfilled within 1 day with a profit of $1.14 (16.62%) receiving and performance score of 166.18.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 15-May-2026
$31
5 months 29 days ago
(15-May-2026)
5/24 (20.83%)
$13.11 (73.28%)
332
Buy Since 20-Jan-2026
$41
$-0.03 (-0.07%)
$26
6 months 27 days ago
(17-Apr-2026)
17/20 (85%)
$0.1 (0.24%)
97
Buy Since 02-Apr-2026
$41
$-0.03 (-0.07%)
$31
7 months 11 days ago
(02-Apr-2026)
2/2 (100%)
$0.59 (1.46%)
26
Hold Since 01-Nov-2023
$41
$-0.03 (-0.07%)
$20
7 months 11 days ago
(02-Apr-2026)
14/18 (77.78%)
$0.59 (1.46%)
148
Buy Since 04-Dec-2017
$41
$-0.03 (-0.07%)
$44
7 months 12 days ago
(01-Apr-2026)
21/28 (75%)
$0.61 (1.51%)
201
Which stock is Eliana Merle most bullish on?
Which stock is Eliana Merle most reserved on?
What Year was the first public recommendation made by Eliana Merle?
